NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

冠狀病毒疫苗的全球市場:2025年為止的預測與市場機會

Global Coronavirus Vaccine Market, By Infection Type, By Vaccine Type, By Product Type, By Route of Administration, By Patient Type, By End User, By Region, Competition Forecast & Opportunities, 2026

出版商 TechSci Research 商品編碼 938722
出版日期 內容資訊 英文 119 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

冠狀病毒疫苗的全球市場:2025年為止的預測與市場機會 Global Coronavirus Vaccine Market, By Infection Type, By Vaccine Type, By Product Type, By Route of Administration, By Patient Type, By End User, By Region, Competition Forecast & Opportunities, 2026
出版日期: 2021年07月01日內容資訊: 英文 119 Pages
簡介

全球冠狀病毒疫苗市場在預測期間內預計將以驚人的年複合成長率成長。 全球冠狀病毒疫苗市場成長的主要因素有在全球各種地區這個疾病的盛行率增加。這增加了對病毒防護的需求,並對市場的增長產生了積極的影響,此外,各種製藥和生物技術公司為研發潛在疫苗而進行的研發活動也不斷增加,從而開拓了市場。有望促進增長。

本報告提供各市場區隔和各地區的全球冠狀病毒疫苗市場調查,提供市場規模及市場佔有率的預測,推動因素與課題,市場趨勢,競爭情形,企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19的影響

第4章 摘要整理

第5章 客戶的迴響

第6章 全球冠狀病毒疫苗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各感染類型(HCoV-229E,HCoV-OC43,SARS-CoV,New Haven CoV,HKU1-CoV,MERS-CoV,SARS-CoV-2,其他)
    • 各疫苗類型(不活化冠狀病毒疫苗,弱毒生冠狀病毒疫苗,S蛋白質為基礎的冠狀病毒疫苗)
    • 各產品類型 (一價疫苗,多價疫苗)
    • 各給藥途徑(口服,肌肉內,皮下)
    • 各患者類型(兒童,成人)
    • 各終端用戶(醫院,診療所,研究機關,其他)
    • 各公司
    • 各地區
  • 產品市場地圖

第7章 亞太地區的冠狀病毒疫苗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各感染類型
    • 各疫苗類型
    • 各產品類型
    • 各給藥途徑
    • 各患者類型
    • 各終端用戶
    • 各國
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國
    • 香港
    • 泰國
    • 新加坡

第8章 歐洲的冠狀病毒疫苗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各感染類型
    • 各疫苗類型
    • 各產品類型
    • 各給藥途徑
    • 各患者類型
    • 各終端用戶
    • 各國
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章 北美的冠狀病毒疫苗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各感染類型
    • 各疫苗類型
    • 各產品類型
    • 各給藥途徑
    • 各患者類型
    • 各終端用戶
    • 各國
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第10章 南美的冠狀病毒疫苗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各感染類型
    • 各疫苗類型
    • 各產品類型
    • 各給藥途徑
    • 各患者類型
    • 各終端用戶
    • 各國
  • 南美:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 中東·非洲的冠狀病毒疫苗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各感染類型
    • 各疫苗類型
    • 各產品類型
    • 各給藥途徑
    • 各患者類型
    • 各終端用戶
    • 各國
  • 中東·非洲:國家分析
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 專利分析

第15章 競爭情形

  • 競爭的展望
  • 企業簡介
  • 公司詳細內容
  • 財務
  • 支援/ 價值鏈分析
  • 從醫藥品開發到銷售的時間軸
    • 疫苗核準情況
  • SWOT分析
  • 主要市場焦點和地理存在
  • 計劃投資
  • 市場定位
  • 主要業者的簡介
    • Inovio Pharmaceuticals, Inc.
    • Moderna, Inc.
    • Novavax, Inc.
    • Johnson & Johnson
    • Pfizer
    • Sanofi
    • Protein Potential, LLC
    • AlphaVax, Inc.
    • Synairgen PLC
    • NanoViricides, Inc.
    • GeneCure, LLC
    • GlaxoSmithKline (GSK)
    • Zydus Cadila
    • Serum Institute
    • Bharat Biotech
    • CanSino Biological Inc
    • FluGen
    • I-Mab Biopharma
    • Medicago
    • Airway Therapeutics

第16章 策略性推薦事項

第17章 免責聲明

目錄
Product Code: 4694

Global coronavirus vaccine market is expected to grow at a robust rate in value terms to reach USD91325.46 million by the end of 2021. Coronaviruses are a group of viruses belonging to the coronaviridae family that can affect both mammals and birds. The common symptoms include mild illness such as common cold, respiratory tract infections, among others.

The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from the saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. The first case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 23rd May 2021, coronavirus has affected more than 200 countries with the total number of coronavirus cases reaching 168,032,098 out of which 149,371,973 have recovered and around 3,488,577 people have succumbed to the disease.

Global coronavirus vaccine market is expected to grow at a robust rate during the forecast period. The global coronavirus vaccine market is driven by the increasing prevalence of this disease across different parts of the globe. This has increased the need to protect the world from the virus, thereby increased sales of coronavirus vaccine through 2026. Furthermore, increasing research and development activities by various pharmaceutical & biotechnology players for the development of potential vaccines is anticipated to foster the market growth. According to WHO, there are more than 70 coronavirus vaccines under development by different companies and organizations.

Currently, mRNA-based vaccine named Moderna COVID-19 Vaccine (mRNA-1273), adenovirus-based vaccine named COVID-19 Vaccine AstraZeneca (AZD1222) also known as Covishield in India and Sputnik V which constitutes recombinant adenovirus vaccine which is developed by Gamaleya Research Institute, Russia are being used for vaccination among adults. The vaccine developed by Moderna, Inc., Pfizer Inc., AstraZeneca PLC are leading the race and is currently administered to entire population. T-COVIDTM, AdCOVID and COVI-VAC are intranasal COVID-19 vaccines which are under pre-clinical and phase 1 trials.

The global coronavirus vaccine market is segmented based on infection type, vaccine type, product type, route of administration, patient type, end user, company, and region. Based on infection type, the market can be categorized into SARS-CoV-2, SARS-CoV and MERS-CoV. The SARS-CoV-2 segment is expected to dominate the market since this infection or virus is the primary cause of the pandemic.

Regionally, the global coronavirus vaccine market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, Asia-Pacific is expected to witness significant growth during the forecast period in the overall coronavirus vaccine market.

Major players operating in the global coronavirus vaccine market include Moderna, Inc., Johnson & Johnson SA, Pfizer Inc., Sinopharm Group Company Ltd., AstraZeneca PLC, are the leading companies and Serum Institute of India Pvt Ltd., Bharat Biotech International Ltd., Sinovac Biotech Ltd., Sanofi SA, GlaxoSmithKline PLC, Novavax, Inc., Airway Therapeutics, Inc., Cadila Healthcare Ltd., CanSino Biologics Inc., Mitsubishi Chemical Holdings Corporation, Eubiologics Co. Ltd., United Biomedical Inc., Merck & Co., Inc., CureVac N.V., Inovio Pharmaceuticals, Inc. among others. The companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and estimate the market size of global coronavirus vaccine market from 2021 to 2026.
  • To estimate and forecast the market size of global coronavirus vaccine market from 2022 to 2026 and growth rate until 2026.
  • To classify and forecast global coronavirus vaccine market based on infection type, vaccine type, product type, route of administration, patient type, end user, company, and regional distribution.
  • To identify dominant region or segment in the global coronavirus vaccine market.
  • To identify drivers and challenges for global coronavirus vaccine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus vaccine market.
  • To conduct pricing analysis for global coronavirus vaccine market.
  • To identify and analyze the profile of leading players operating in global coronavirus vaccine market.
  • To identify key sustainable strategies adopted by market players in global coronavirus vaccine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global coronavirus vaccine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Coronavirus vaccine manufacturers, suppliers, distributors, and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to coronavirus vaccine
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global coronavirus vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Coronavirus Vaccine Market, By Infection Type:

  • SARS-CoV-2
  • SARS-CoV
  • MERS-CoV

Global Coronavirus Vaccine Market, By Vaccine Type:

  • Virus Vaccine
  • Viral Vector Vaccine
  • Nucleic Acid Vaccine
  • Protein Based Vaccine
  • Others

Global Coronavirus Vaccine Market, By Product Type:

  • Monovalent Vaccine
  • Multivariant Vaccine

Global Coronavirus Vaccine Market, By Route of Administration:

  • Intramuscular
  • Oral
  • Intranasal

Global Coronavirus Vaccine Market, By Patient Type:

  • Adult
  • Pediatric

Global Coronavirus Vaccine Market, By End User:

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

Global Coronavirus Vaccine Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Singapore
    • Japan
    • South Korea
    • Hong Kong
    • Australia
    • Thailand
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Coronavirus Vaccine Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness
  • 5.2. Vaccine Efficacy
  • 5.3. Patient Satisfaction Analysis
  • 5.4. Post-Vaccination Side Effects

6. Global Coronavirus Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value and By Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV)
    • 6.2.2. By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine, Others)
    • 6.2.3. By Product Type (Monovalent Vaccine v/s Multivariant Vaccine)
    • 6.2.4. By Route of Administration (Intramuscular, Oral, Intranasal)
    • 6.2.5. By Patient Type (Adult v/s Pediatric)
    • 6.2.6. By End User (Hospitals, Clinics, Research Institutes, Others)
    • 6.2.7. By Company (2020)
    • 6.2.8. By Region
  • 6.3. Market Map

7. North America Coronavirus Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Infection Type
    • 7.2.2. By Vaccine Type
    • 7.2.3. By Product Type
    • 7.2.4. By Route of Administration
    • 7.2.5. By Patient Type
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Coronavirus Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Infection Type
        • 7.3.1.2.2. By Vaccine Type
        • 7.3.1.2.3. By Product Type
        • 7.3.1.2.4. By Route of Administration
        • 7.3.1.2.5. By Patient Type
        • 7.3.1.2.6. By End User
    • 7.3.2. Mexico Coronavirus Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Infection Type
        • 7.3.2.2.2. By Vaccine Type
        • 7.3.2.2.3. By Product Type
        • 7.3.2.2.4. By Route of Administration
        • 7.3.2.2.5. By Patient Type
        • 7.3.2.2.6. By End User
    • 7.3.3. Canada Coronavirus Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Infection Type
        • 7.3.3.2.2. By Vaccine Type
        • 7.3.3.2.3. By Product Type
        • 7.3.3.2.4. By Route of Administration
        • 7.3.3.2.5. By Patient Type
        • 7.3.3.2.6. By End User

8. Europe Coronavirus Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Infection Type
    • 8.2.2. By Vaccine Type
    • 8.2.3. By Product Type
    • 8.2.4. By Route of Administration
    • 8.2.5. By Patient Type
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. United Kingdom Coronavirus Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Infection Type
        • 8.3.1.2.2. By Vaccine Type
        • 8.3.1.2.3. By Product Type
        • 8.3.1.2.4. By Route of Administration
        • 8.3.1.2.5. By Patient Type
        • 8.3.1.2.6. By End User
    • 8.3.2. Germany Coronavirus Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Infection Type
        • 8.3.2.2.2. By Vaccine Type
        • 8.3.2.2.3. By Product Type
        • 8.3.2.2.4. By Route of Administration
        • 8.3.2.2.5. By Patient Type
        • 8.3.2.2.6. By End User
    • 8.3.3. France Coronavirus Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Infection Type
        • 8.3.3.2.2. By Vaccine Type
        • 8.3.3.2.3. By Product Type
        • 8.3.3.2.4. By Route of Administration
        • 8.3.3.2.5. By Patient Type
        • 8.3.3.2.6. By End User
    • 8.3.4. Italy Coronavirus Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Infection Type
        • 8.3.4.2.2. By Vaccine Type
        • 8.3.4.2.3. By Product Type
        • 8.3.4.2.4. By Route of Administration
        • 8.3.4.2.5. By Patient Type
        • 8.3.4.2.6. By End User
    • 8.3.5. Spain Coronavirus Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Infection Type
        • 8.3.5.2.2. By Vaccine Type
        • 8.3.5.2.3. By Product Type
        • 8.3.5.2.4. By Route of Administration
        • 8.3.5.2.5. By Patient Type
        • 8.3.5.2.6. By End User

9. Asia-Pacific Coronavirus Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Infection Type
    • 9.2.2. By Vaccine Type
    • 9.2.3. By Product Type
    • 9.2.4. By Route of Administration
    • 9.2.5. By Patient Type
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Coronavirus Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Infection Type
        • 9.3.1.2.2. By Vaccine Type
        • 9.3.1.2.3. By Product Type
        • 9.3.1.2.4. By Route of Administration
        • 9.3.1.2.5. By Patient Type
        • 9.3.1.2.6. By End User
    • 9.3.2. India Coronavirus Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Infection Type
        • 9.3.2.2.2. By Vaccine Type
        • 9.3.2.2.3. By Product Type
        • 9.3.2.2.4. By Route of Administration
        • 9.3.2.2.5. By Patient Type
        • 9.3.2.2.6. By End User
    • 9.3.3. Singapore Coronavirus Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Infection Type
        • 9.3.3.2.2. By Vaccine Type
        • 9.3.3.2.3. By Product Type
        • 9.3.3.2.4. By Route of Administration
        • 9.3.3.2.5. By Patient Type
        • 9.3.3.2.6. By End User
    • 9.3.4. Japan Coronavirus Vaccine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Infection Type
        • 9.3.4.2.2. By Vaccine Type
        • 9.3.4.2.3. By Product Type
        • 9.3.4.2.4. By Route of Administration
        • 9.3.4.2.5. By Patient Type
        • 9.3.4.2.6. By End User
    • 9.3.5. South Korea Coronavirus Vaccine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Infection Type
        • 9.3.5.2.2. By Vaccine Type
        • 9.3.5.2.3. By Product Type
        • 9.3.5.2.4. By Route of Administration
        • 9.3.5.2.5. By Patient Type
        • 9.3.5.2.6. By End User
    • 9.3.6. Hong Kong Coronavirus Vaccine Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Infection Type
        • 9.3.6.2.2. By Vaccine Type
        • 9.3.6.2.3. By Product Type
        • 9.3.6.2.4. By Route of Administration
        • 9.3.6.2.5. By Patient Type
        • 9.3.6.2.6. By End User
    • 9.3.7. Australia Coronavirus Vaccine Market Outlook
      • 9.3.7.1. Market Size & Forecast
        • 9.3.7.1.1. By Value
      • 9.3.7.2. Market Share & Forecast
        • 9.3.7.2.1. By Infection Type
        • 9.3.7.2.2. By Vaccine Type
        • 9.3.7.2.3. By Product Type
        • 9.3.7.2.4. By Route of Administration
        • 9.3.7.2.5. By Patient Type
        • 9.3.7.2.6. By End User
    • 9.3.8. Thailand Coronavirus Vaccine Market Outlook
      • 9.3.8.1. Market Size & Forecast
        • 9.3.8.1.1. By Value
      • 9.3.8.2. Market Share & Forecast
        • 9.3.8.2.1. By Infection Type
        • 9.3.8.2.2. By Vaccine Type
        • 9.3.8.2.3. By Product Type
        • 9.3.8.2.4. By Route of Administration
        • 9.3.8.2.5. By Patient Type
        • 9.3.8.2.6. By End User

10. South America Coronavirus Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Infection Type
    • 10.2.2. By Vaccine Type
    • 10.2.3. By Product Type
    • 10.2.4. By Route of Administration
    • 10.2.5. By Patient Type
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Coronavirus Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Infection Type
        • 10.3.1.2.2. By Vaccine Type
        • 10.3.1.2.3. By Product Type
        • 10.3.1.2.4. By Route of Administration
        • 10.3.1.2.5. By Patient Type
        • 10.3.1.2.6. By End User
    • 10.3.2. Argentina Coronavirus Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Infection Type
        • 10.3.2.2.2. By Vaccine Type
        • 10.3.2.2.3. By Product Type
        • 10.3.2.2.4. By Route of Administration
        • 10.3.2.2.5. By Patient Type
        • 10.3.2.2.6. By End User
    • 10.3.3. Colombia Coronavirus Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Infection Type
        • 10.3.3.2.2. By Vaccine Type
        • 10.3.3.2.3. By Product Type
        • 10.3.3.2.4. By Route of Administration
        • 10.3.3.2.5. By Patient Type
        • 10.3.3.2.6. By End User

11. Middle East and Africa Coronavirus Vaccine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Infection Type
    • 11.2.2. By Vaccine Type
    • 11.2.3. By Product Type
    • 11.2.4. By Route of Administration
    • 11.2.5. By Patient Type
    • 11.2.6. By End User
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. UAE Coronavirus Vaccine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Infection Type
        • 11.3.1.2.2. By Vaccine Type
        • 11.3.1.2.3. By Product Type
        • 11.3.1.2.4. By Route of Administration
        • 11.3.1.2.5. By Patient Type
        • 11.3.1.2.6. By End User
    • 11.3.2. Saudi Arabia Coronavirus Vaccine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Infection Type
        • 11.3.2.2.2. By Vaccine Type
        • 11.3.2.2.3. By Product Type
        • 11.3.2.2.4. By Route of Administration
        • 11.3.2.2.5. By Patient Type
        • 11.3.2.2.6. By End User
    • 11.3.3. Kuwait Coronavirus Vaccine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Infection Type
        • 11.3.3.2.2. By Vaccine Type
        • 11.3.3.2.3. By Product Type
        • 11.3.3.2.4. By Route of Administration
        • 11.3.3.2.5. By Patient Type
        • 11.3.3.2.6. By End User
    • 11.3.4. South Africa Coronavirus Vaccine Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Infection Type
        • 11.3.4.2.2. By Vaccine Type
        • 11.3.4.2.3. By Product Type
        • 11.3.4.2.4. By Route of Administration
        • 11.3.4.2.5. By Patient Type
        • 11.3.4.2.6. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Moderna, Inc.
    • 14.2.2. Pfizer Inc.
    • 14.2.3. Johnson & Johnson SA
    • 14.2.4. Sinopharm Group Company Ltd.
    • 14.2.5. AstraZeneca PLC
    • 14.2.6. Serum Institute of India Pvt Ltd.
    • 14.2.7. Bharat Biotech International Ltd.
    • 14.2.8. Sinovac Biotech Ltd.
    • 14.2.9. Sanofi SA
    • 14.2.10. GlaxoSmithKline PLC
    • 14.2.11. Novavax, Inc.
    • 14.2.12. Airway Therapeutics, Inc.
    • 14.2.13. Cadila Healthcare Ltd.
    • 14.2.14. CanSino Biologics Inc.
    • 14.2.15. Mitsubishi Chemical Holdings Corporation
    • 14.2.16. Eubiologics Co. Ltd.
    • 14.2.17. United Biomedical Inc.
    • 14.2.18. Merck & Co., Inc.
    • 14.2.19. CureVac N.V.
    • 14.2.20. Inovio Pharmaceuticals, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
  • Figure 2: Global Coronavirus Vaccine Market Share, By Volume (Million Units), 2020-2026F
  • Figure 3: Global Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 4: Global Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 5: Global Coronavirus Vaccine Market Share, By Product Type, By Value 2020-2026F
  • Figure 6: Global Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 7: Global Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 8: Global Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 9: Global Coronavirus Vaccine Market Share, Market Map, By Region, By Value, 2020-2026F
  • Figure 10: North America Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
  • Figure 11: North America Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 12: North America Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 13: North America Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 14: North America Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 15: North America Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 16: North America Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 17: North America Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
  • Figure 18: United States Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 19: United States Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 20: United States Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 21: United States Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 22: United States Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 23: United States Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 24: Mexico Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 25: Mexico Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 26: Mexico Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 27: Mexico Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 28: Mexico Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 29: Mexico Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 30: Canada Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 31: Canada Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 32: Canada Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 33: Canada Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 34: Canada Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 35: Canada Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 36: Europe Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
  • Figure 37: Europe Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 38: Europe Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 39: Europe Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 40: Europe Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 41: Europe Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 42: Europe Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 43: Europe Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
  • Figure 44: United Kingdom Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 45: United Kingdom Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 46: United Kingdom Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 47: United Kingdom Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 48: United Kingdom Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 49: United Kingdom Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 50: Germany Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 51: Germany Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 52: Germany Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 53: Germany Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 54: Germany Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 55: Germany Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 56: France Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 57: France Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 58: France Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 59: France Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 60: France Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 61: France Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 62: Italy Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 63: Italy Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 64: Italy Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 65: Italy Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 66: Italy Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 67: Italy Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 68: Spain Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 69: Spain Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 70: Spain Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 71: Spain Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 72: Spain Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 73: Spain Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 74: APAC Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
  • Figure 75: APAC Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 76: APAC Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 77: APAC Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 78: APAC Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 79: APAC Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 80: APAC Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 81: APAC Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
  • Figure 82: China Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 83: China Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 84: China Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 85: China Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 86: China Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 87: China Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 88: India Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 89: India Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 90: India Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 91: India Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 92: India Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 93: India Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 94: Singapore Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 95: Singapore Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 96: Singapore Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 97: Singapore Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 98: Singapore Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 99: Singapore Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 100: Japan Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 101: Japan Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 102: Japan Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 103: Japan Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 104: Japan Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 105: Japan Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 106: South Korea Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 107: South Korea Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 108: South Korea Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 109: South Korea Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 110: South Korea Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 111: South Korea Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 112: Hong Kong Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 113: Hong Kong Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 114: Hong Kong Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 115: Hong Kong Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 116: Hong Kong Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 117: Hong Kong Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 118: Australia Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 119: Australia Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 120: Australia Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 121: Australia Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 122: Australia Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 123: Australia Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 124: Thailand Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 125: Thailand Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 126: Thailand Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 127: Thailand Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 128: Thailand Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 129: Thailand Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 130: South America Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
  • Figure 131: South America Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 132: South America Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 133: South America Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 134: South America Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 135: South America Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 136: South America Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 137: South America Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
  • Figure 138: Brazil Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 139: Brazil Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 140: Brazil Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 141: Brazil Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 142: Brazil Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 143: Brazil Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 144: Argentina Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 145: Argentina Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 146: Argentina Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 147: Argentina Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 148: Argentina Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 149: Argentina Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 150: Colombia Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 151: Colombia Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 152: Colombia Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 153: Colombia Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 154: Colombia Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 155: Colombia Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 156: MEA Coronavirus Vaccine Market Share, By Value (USD Million), 2020-2026F
  • Figure 157: MEA Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 158: MEA Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 159: MEA Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 160: MEA Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 161: MEA Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 162: MEA Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 163: MEA Coronavirus Vaccine Market Share, By Country, By Value, 2020-2026F
  • Figure 164: UAE Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 165: UAE Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 166: UAE Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 167: UAE Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 168: UAE Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 169: UAE Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 170: Saudi Arabia Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 171: Saudi Arabia Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 172: Saudi Arabia Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 173: Saudi Arabia Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 174: Saudi Arabia Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 175: Saudi Arabia Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 176: Kuwait Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 177: Kuwait Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 178: Kuwait Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 179: Kuwait Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 180: Kuwait Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 181: Kuwait Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F
  • Figure 182: South Africa Coronavirus Vaccine Market Share, By Infection Type, By Value, 2020-2026F
  • Figure 183: South Africa Coronavirus Vaccine Market Share, By Vaccine Type, By Value, 2020-2026F
  • Figure 184: South Africa Coronavirus Vaccine Market Share, By Product Type, By Value, 2020-2026F
  • Figure 185: South Africa Coronavirus Vaccine Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 186: South Africa Coronavirus Vaccine Market Share, By Patient Type, By Value, 2020-2026F
  • Figure 187: South Africa Coronavirus Vaccine Market Share, By End User, By Value, 2020-2026F